Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion type Assertion NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_head.
- NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion description "[Therapeutic measures include interferon-alpha for CDA I, splenectomy for CDA II, and iron depletion for all individuals at risk for secondary hemochromatosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_provenance.
- NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion evidence source_evidence_literature NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_provenance.
- NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion SIO_000772 15278299 NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_provenance.
- NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion wasDerivedFrom befree-20140225 NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_provenance.
- NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_assertion wasGeneratedBy ECO_0000203 NP556795.RAnpuy916LvILFytBhcdiJVhi65bJmDKggzfwfqS_qK00130_provenance.